Physician profile
John Boyd
NPI 1467808915
$7,237.74
in general payments reported to CMS, 2019-2025
26 companies · $728 in 2025
The $728 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $1,362 · 2021: $1,335 · 2022: $65.71 · 2023: $1,361 · 2024: $1,058 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960 · Travel and Lodging: $1,039 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,959.69 |
| Travel and Lodging | $1,038.89 |
| Education | $148.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $2,454.60 | 2020-2021 | |
| Stryker Corporation | $1,942.87 | 2019-2025 | Prostep, Valor, Salvation |
| Zimmer Biomet Holdings, INC. | $798.21 | 2019 | |
| Smith+Nephew, INC. | $508.48 | 2020-2025 | Grafix Pl, Stravix, Grafix |
| Organogenesis INC. | $338.22 | 2021-2025 | Novachor, Puraply, Apligraf |
| Averitas Pharma INC. | $292.13 | 2024-2025 | Qutenza |
| Convatec INC. | $170.10 | 2023 | |
| Paratek Pharmaceuticals, INC. | $156.39 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $109.80 | 2019 | |
| Misonix INC | $86.75 | 2020 | |
| Abbott Laboratories | $39.04 | 2024 | Octrode, Proclaim |
| Orthofix Medical, INC. | $38.54 | 2024-2025 | Physio-Stim |
| Paragon 28, INC. | $37.17 | 2025 | Plating Portfolio, Mtp |
| Ibsa Pharma INC. | $36.20 | 2025 | Flector, Tirosint, Licart |
| Medtronic, INC. | $25.70 | 2023 | Intellis Adaptivestim |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $24.92 | 2024 | |
| Osteomed LLC | $24.89 | 2019 | |
| Kci USA, INC. | $23.80 | 2019 | |
| Nevro Corp. | $20.94 | 2024 | Senza |
| Depuy Synthes Sales INC. | $20.34 | 2025 | Motoband |
| Treace Medical Concepts, INC. | $18.85 | 2024 | |
| Amgen INC. | $16.28 | 2024 | Krystexxa |
| Vivus LLC | $14.62 | 2022 | |
| Bioventus LLC | $14.00 | 2025 | Exogen Ultrasound Bone Healing System |
| Wright Medical Technology, INC. | $13.79 | 2019 | |
| Merck Sharp & Dohme LLC | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.